CRIS Current Research Information System

MANERBA, MARCELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.387
AS - Asia 1.865
EU - Europa 1.416
AF - Africa 167
SA - Sud America 113
Continente sconosciuto - Info sul continente non disponibili 100
OC - Oceania 7
Totale 6.055
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.354
VN - Vietnam 501
CN - Cina 486
SG - Singapore 477
IT - Italia 341
GB - Regno Unito 282
DE - Germania 151
HK - Hong Kong 112
SE - Svezia 109
IN - India 98
FR - Francia 87
BR - Brasile 85
RU - Federazione Russa 68
CH - Svizzera 67
UA - Ucraina 61
IE - Irlanda 56
TG - Togo 52
CI - Costa d'Avorio 42
NL - Olanda 42
FI - Finlandia 39
JP - Giappone 32
KR - Corea 29
ZA - Sudafrica 28
BG - Bulgaria 27
BD - Bangladesh 26
NG - Nigeria 24
JO - Giordania 21
EE - Estonia 19
BE - Belgio 16
CA - Canada 15
PH - Filippine 14
TH - Thailandia 12
AR - Argentina 11
AT - Austria 11
ES - Italia 11
ID - Indonesia 11
MX - Messico 11
TW - Taiwan 10
IQ - Iraq 8
SA - Arabia Saudita 8
SC - Seychelles 8
PL - Polonia 7
AU - Australia 6
PK - Pakistan 5
TR - Turchia 5
CO - Colombia 4
EC - Ecuador 4
EG - Egitto 4
LT - Lituania 4
PY - Paraguay 4
RO - Romania 4
JM - Giamaica 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
GR - Grecia 2
HR - Croazia 2
KE - Kenya 2
LB - Libano 2
MA - Marocco 2
NI - Nicaragua 2
NP - Nepal 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BT - Bhutan 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
MD - Moldavia 1
ME - Montenegro 1
MU - Mauritius 1
MW - Malawi 1
NC - Nuova Caledonia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SI - Slovenia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.955
Salva come PNG Salva come JPEG
Città #
Singapore 336
Ashburn 308
Fairfield 246
Southend 244
Chandler 209
Woodbridge 138
Bologna 129
Hong Kong 108
Ho Chi Minh City 106
Houston 106
Santa Clara 106
San Jose 100
Seattle 99
Hanoi 93
Wilmington 93
Ann Arbor 80
Cambridge 76
Dong Ket 75
Bern 64
Beijing 60
Princeton 57
Dublin 56
Hefei 56
Lomé 52
Abidjan 42
Redmond 40
Boardman 37
New York 36
Lauterbourg 33
Helsinki 31
Jacksonville 31
Los Angeles 29
Sofia 27
Nanjing 26
Abeokuta 24
Tokyo 24
Westminster 23
Buffalo 21
Seoul 21
Shenyang 21
Amman 20
Padova 20
Da Nang 19
Council Bluffs 18
Berlin 17
Guangzhou 17
Haiphong 17
San Diego 17
Milan 16
Brussels 15
Jalandhar 15
Frankfurt am Main 14
Turin 12
Saint Petersburg 11
Shanghai 11
Tianjin 11
Dallas 10
Rome 10
Changsha 9
Des Moines 9
Falls Church 9
Jinan 9
Yubileyny 9
Amsterdam 8
Falkenstein 8
Mülheim 8
Nanchang 8
Phoenix 8
Bremen 7
Chennai 7
Florence 7
Haikou 7
Hangzhou 7
Jakarta 7
Nuremberg 7
São Paulo 7
Baghdad 6
Belo Horizonte 6
Brooklyn 6
Düsseldorf 6
Hebei 6
Johannesburg 6
London 6
Mexico City 6
Redondo Beach 6
The Dalles 6
Turku 6
Warsaw 6
Biên Hòa 5
Can Tho 5
Mahé 5
Montreal 5
Nha Trang 5
Paris 5
Quận Bình Thạnh 5
Redwood City 5
Rimini 5
Thái Nguyên 5
Tân Tiến 5
Wuhan 5
Totale 4.006
Salva come PNG Salva come JPEG
Nome #
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib 282
Rad51/Brca2 Disruptors Inhibit Homologous Recombination and Synergize with Olaparib in Pancreatic Cancer Cells 277
Lactate dehydrogenase inhibition affects homologous recombination repair independently of cell metabolic asset; implications for anticancer treatment 239
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 238
Altered glycosylation profile of purified plasma ACT from Alzheimer's disease. 230
Lactate dehydrogenase inhibitors can reverse inflammation induced changes in colon cancer cells 228
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. 226
LDH inhibition impacts on heat shock response and induces senescence of hepatocellular carcinoma cells 221
The activation of lactate dehydrogenase induced by mTOR drives neoplastic change in breast epithelial cells 217
Effect of copper on extracellular levels of key pro-inflammatory molecules in hypothalamic GN11 and primary neurons. 216
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. 213
Lactate dehydrogenase inhibitors sensitize lymphoma cells to cisplatin without enhancing the drug effects on immortalized normal lymphocytes. 207
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. 202
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. 202
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors 198
Synthesis of natural urolithin M6, a galloflavin mimetic, as a potential inhibitor of lactate dehydrogenase A 193
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. 186
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulationin Burkitt lymphoma cells via NAD/NADH-dependent inhibition of sirtuin-1 186
Metabolic activation triggered by cAMP in MCF-7 cells generates lethal vulnerability to combined oxamate/etomoxir 177
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination 171
Albumin-drug conjugates in the treatment of hepatic disorders. 171
Dihydroquinoline pyrazoline-based compound as a new RAD51-BRCA2 protein-protein disruptor to trigger synthetic lethality in pancreatic cancer 169
The enhancement of interstitial transport of a doxorubicin-lactosaminated albumin conjugate by imatinib: in rat hepatocellular carcinoma it is not preferentially higher than that in liver and bone marrow. 168
Lactate Upregulates the Expression of DNA Repair Genes, Causing Intrinsic Resistance of Cancer Cells to Cisplatin 158
Identification of N-acylhydrazone derivatives as novel lactate dehydrogenase A inhibitors 139
NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases 133
Design and synthesis of BRCA2-RAD51 disruptors to induce synthetic lethality in anticancer therapy 122
Lactate dehydrogenase inhibition: Exploring possible applications beyond cancer treatment 122
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy 110
null 101
RAD51 nuclear recruitment and inhibition towards innovative strategies against pancreatic cancer 88
null 78
null 71
Design and synthesis of RAD51-BRCA2 disruptors to inhibit homologous recombination and synergize with Olaparib as new anticancer drug discovery concept 65
null 51
Totale 6.055
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.687
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022530 0 10 45 44 48 28 27 53 29 37 116 93
2022/2023817 61 125 26 107 78 54 28 34 134 26 37 107
2023/2024202 13 31 9 25 10 66 8 4 4 15 2 15
2024/2025780 44 75 62 76 135 34 52 39 20 71 37 135
2025/20261.945 171 173 134 180 192 92 163 69 500 162 64 45
2026/202758 38 20 0 0 0 0 0 0 0 0 0 0
Totale 6.055